Provided by Tiger Trade Technology Pte. Ltd.

INNOCARE

12.790
-0.720-5.33%
Volume:8.67M
Turnover:113.55M
Market Cap:22.60B
PE:28.75
High:13.860
Open:13.800
Low:12.730
Close:13.510
52wk High:20.180
52wk Low:9.650
Shares:1.77B
HK Float Shares:1.49B
Volume Ratio:2.76
T/O Rate:0.58%
Dividend:- -
Dividend Rate:- -
EPS(LYR):0.445
ROE:12.77%
ROA:4.28%
PB:2.52
PE(LYR):28.75
PS:6.94

Loading ...

InnoCare Pharma - to Advance Compounds Against up to Five Targets for Unmet Medical Needs

THOMSON REUTERS
·
Sep 24

InnoCare Pharma - Eligible for up to $100 Mln Upfront and $3.25 Bln in Milestone Payments

THOMSON REUTERS
·
Sep 24

InnoCare Pharma - Eligible to Receive Single-Digit Tiered Royalties on Net Product Sales

THOMSON REUTERS
·
Sep 24

InnoCare Pharma - Enters Strategic Collaboration and License Agreement with Eli Lilly

THOMSON REUTERS
·
Sep 24

Movement Alert|INNOCARE Falls 5.02% in Regular Trading, Biotech Sector Broadly Retreats After Recent Rally

Market Focus
·
Sep 24

InnoCare Pharma Records First-Half Profit as Revenue Jumps 55.5%, Backed by Orelabrutinib Expansion

Bulletin Express
·
Sep 22

HK Movers | Innovative Drug Stocks Rally Broadly; LEPU BIO, INNOCARE, AKESO Jump Over 7%

Tiger Newspress
·
Sep 21

Movement Alert|INNOCARE Rises 5.1% in Regular Trading, First Bispecific ADC ICP-B381 Approved for Clinical Trials

Market Focus
·
Sep 21

InnoCare Issues 0.58 Million New RMB Shares Under 2024 Incentive Scheme; Hong Kong Share Count Unchanged

Bulletin Express
·
Sep 17

Hong Kong Stocks Recover as WCLC Conference Sparks Biotech Rally, While US AI Slowdown Calls Raise Questions

Stock News
·
Sep 14

Hong Kong Stocks Close Mixed as Healthcare Advances, Memory Shares Slump

Deep News
·
Sep 14

HK Stocks in Focus: Innovative Drug Sector Surges on WCLC Data Boost, Analysts See Value After Pullback

Stock News
·
Sep 14

Movement Alert|INNOCARE Rises 8.12% in Regular Trading, Dual-Antibody ADC ICP-B381 Approved for Clinical Trials

Market Focus
·
Sep 14

Hong Kong Stock Market Moves | INNOCARE (09969) Surges Over 5% as Its PSMA/STEAP1 Bispecific ADC ICP-B381 Receives Clinical Trial Approval

Stock News
·
Sep 14

Movement Alert|INNOCARE Falls 5.73% in Regular Trading, Biotech Sector Broadly Weak as National Insurance Negotiation Concludes

Market Focus
·
Sep 10

InnoCare Gets First Half of Remaining Stake Bought in Subsidiary

MT Newswires Live
·
Sep 08

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

Stock News
·
Sep 07

Assessing the Value of InnoCare's ICP-488 in the Psoriasis Market

Deep News
·
Sep 04

Movement Alert|INNOCARE Rises 5.48% in Regular Trading, Multiple Institutions Issue Buy Ratings Amid Strong H1 Earnings

Market Focus
·
Sep 04

Party Time: Brokers Just Made Major Increases To Their InnoCare Pharma Limited (HKG:9969) Earnings Forecasts

Simply Wall St.
·
Aug 30